Let's Talk... SMA at EPNS 2022

External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

May 26 / Springer Healthcare

Let's Talk... SMA at EPNS 2022

Neuroscience Spinal Muscular Atrophy EPNS-2022

Description

For this episode, we talk to Mariacristina Scoto about real-world studies on disease-modifying treatments for spinal muscular atrophy, and take a look at how some of the data presented at EPNS 2022 could impact clinical practice.

Follow us here

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.